Unjoni Ewropea - Finlandiż - EMA (European Medicines Agency)

recordati rare diseases - ibuprofeeni - ductus arteriosus, patentti - sydämen hoito - hoidossa haemodynamically merkittävä avoimen valtimotiehyen vastasyntyneen keskosilla vähemmän kuin 34 viikkoa gestaatioikään.

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

takeda oy - atropine sulfate - injektioneste, liuos - 1 mg/ml - atropiini

Unjoni Ewropea - Finlandiż - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - porsaiden vastasyntyneen enterotoksikoosin väheneminen e: n aiheuttamana. coli-kannoista, jotka ekspressoivat adhesiineja f4ab, f4ac, f4ad, f5, f6 ja f41 ensimmäisten elämänpäivien aikana.

Unjoni Ewropea - Finlandiż - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologiset suidaeille - siat - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Unjoni Ewropea - Finlandiż - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - siat - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

ceva-phylaxia co. ltd - ib virus, massachusetts type, b48 strain - kuiva-aine, kylmäkuivattu, suspensiota varten, silmiin ja sieraimiin - lintujen tarttuva keuhkoputkentulehdus virus -rokote

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

haleon denmark aps - paracetamol - oraalisuspensio - 24 mg/ml - parasetamoli

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

viatris oy - methenamine hippurate - tabletti - 1 g - metenamiini

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

haleon denmark aps - paracetamol - poretabletti - 500 mg - parasetamoli

Finlandja - Finlandiż - Fimea (Suomen lääkevirasto)

haleon denmark aps - paracetamol - peräpuikko - 125 mg - parasetamoli